Copy-Number Variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism

Human Mutation

Volumn 30, Issue 9, 2009, Pages 1310-1319

  Ménard, Vincent ^b   Eap, Olivier ^b   Harvey, Mario ^b   Guillemette, Chantal ^b   Lévesque, Éric ^a  

^a Université Laval   (Canada)

^b NONE

Author keywords

CNV; UGT2B15; UGT2B17; UGT2B28

Indexed keywords

PURINE; SEX HORMONE;

ANALYSIS; ARTICLE; CAUCASIAN; CHROMOSOME; CONTROLLED STUDY; GENE; GENE DELETION; GENE DUPLICATION; GENE NUMBER; GENETIC POLYMORPHISM; GENOMICS; GENOTYPE; HAPLOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRIORITY JOURNAL; UGT2B15 GENE; UGT2B17 GENE; UGT2B28 GENE;

BASE SEQUENCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DOSAGE; GENETIC VARIATION; GENOTYPE; GLUCURONOSYLTRANSFERASE; GONADAL STEROID HORMONES; HAPLOTYPES; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 69549121731     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21054     Document Type: Article

References (41)

1. Barbier O, Levesque E, Belanger A, Hum DW. 1999. UGT2B23, a novel uridine diphosphate-glucuronosyltransferase enzyme expressed in steroid target tissues that conjugates androgen and estrogen metabolites. Endocrinology 140:5538-5548. (Pubitemid 30645341)
2. Beaulieu M, Levesque E, Hum DW, Belanger A. 1996. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862. (Pubitemid 26304735)
3. Beaulieu M, Levesque E, Barbier O, Turgeon D, Belanger G, Hum DW, Belanger A. 1998a. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens. J Mol Biol 275:785-794. (Pubitemid 28077696)
4. Beaulieu M, Levesque E, Hum DW, Belanger A. 1998b. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 248:44-50. (Pubitemid 28418184)
5. Belanger G, Beaulieu M, Levesque E, Hum DW, Belanger A. 1997. Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey. DNA Cell Biol 16:1195-1205. (Pubitemid 27479387)
6. Belanger A, Hum DW, Beaulieu M, Levesque E, Guillemette C, Tchernof A, Belanger G, Turgeon D, Dubois S. 1998. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 65:301-310. (Pubitemid 28335617)
7. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S. 2003. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479. (Pubitemid 37517349)
8. Chouinard S, Pelletier G, Belanger A, Barbier O. 2004. Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. Endocr Res 30:717-725. (Pubitemid 40070159)
9. Chouinard S, Barbier O, Belanger A. 2007. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J Biol Chem 282:33466-33474. (Pubitemid 350159554)
10. Evans WE, Relling MV. 1999. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487-491.
11. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M and others. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
12. Gallagher CJ, Kadlubar FF, Muscat JE, Ambrosone CB, Lang NP, Lazarus P. 2007. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev 31:310-315.
13. Guillemette C, Levesque E, Beaulieu M, Turgeon D, Hum DW, Belanger A. 1997. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138:2998-3005. (Pubitemid 27258534)
14. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. 2000. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10:629-644. (Pubitemid 30769712)
15. Hughes JF, Skaletsky H, Pyntikova T, Minx PJ, Graves T, Rozen S, Wilson RK, Page DC. 2005. Conservation of Y-linked genes during human evolution revealed by comparative sequencing in chimpanzee. Nature 437:100-103.
16. Hum DW, Belanger A, Levesque E, Barbier O, Beaulieu M, Albert C, Vallee M, Guillemette C, Tchernof A, Turgeon D and others. 1999. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol 69:413-423.
17. Jakobsson J, Ekstrom L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlstrom K, Rane A. 2006. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687-693. (Pubitemid 43236944)
18. Joshi N, Johnson LL, Wei WQ, Abnet CC, Dong ZW, Taylor PR, Limburg PJ, Dawsey SM, Hawk ET, Qiao YL and others. 2006. Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res 66:6851-6860.
19. Karypidis AH, Olsson M, Andersson SO, Rane A, Ekstrom L. 2007. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J 27:27.
20. Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, Hum DW. 1997. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325. (Pubitemid 27356932)
21. Levesque E, Turgeon D, Carrier JS, Montminy V, Beaulieu M, Belanger A. 2001. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40:3869-3881. (Pubitemid 32280423)
22. Levesque E, Delage R, Benoit-Biancamano MO, Caron P, Bernard O, Couture F, Guillemette C. 2007. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. Clin Pharmacol Ther 81:392-400. (Pubitemid 46364482)
23. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel- Gigleux S, Green M, Hum DW, Iyanagi T and others. 1997. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
24. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. 2005. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685. (Pubitemid 41345319)
25. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, Dallaire S, Gabriel SB, Lee C, Daly MJ and others. 2006. Common deletion polymorphisms in the human genome. Nat Genet 38:86-92.
26. Murata M, Warren EH, Riddell SR. 2003. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 197:1279-1289. (Pubitemid 36617774)
27. Olsson M, Lindstrom S, Haggkvist B, Adami HO, Balter K, Stattin P, Ask B, Rane A, Ekstrom L, Gronberg H. 2008. The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 4:4.
28. Park J, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB and others. 2006. Deletion polymorphism of UDPglucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev 15:1473-1478.
29. Park J, Chen L, Shade K, Lazarus P, Seigne J, Patterson S, Helal M, Pow-Sang J. 2004. Asp 85Tyr polymorphism in the UDP-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol 171(6 Pt 1):2484-2488. (Pubitemid 38625520)
30. Park JY, Tanner JP, Sellers TA, Huang Y, Stevens CK, Dossett N, Shankar RA, Zachariah B, Heysek R, Pow-Sang J. 2007. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70:374-379. (Pubitemid 47362236)
31. Relton CL, Freathy RM, Ring SM, Groom A, Gray R, Hattersley AT, Frayling TM, Davey Smith G. The influence of metabolic polymorphisms and smoking during pregnancy on fetal growth and preterm delivery. 2008. 58th Annual Meeting of the American Society for Human Genetics (ASHG), Philadelphia, Pennsylvania, November 11-15, 2008.
32. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekstrom L, Rane A. 2008. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93:2500-2506. (Pubitemid 352008513)
33. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. 2007. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 39:226-231. (Pubitemid 46184354)
34. Swanson C, Lorentzon M, Vandenput L, Labrie F, Rane A, Jakobsson J, Chouinard S, Belanger A, Ohlsson C. 2007. Sex steroid levels and cortical bone size in young men are associated with a uridine diphosphate glucuronosyltransferase 2B7 polymorphism (H268Y). J Clin Endocrinol Metab 92:3697-3704. (Pubitemid 47435358)
35. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989. (Pubitemid 32289743)
36. Tukey RH, Strassburg CP. 2000. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616. (Pubitemid 30340694)
37. Turgeon D, Carrier JS, Levesque E, Beatty BG, Belanger A, Hum DW. 2000. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489-504. (Pubitemid 30695086)
38. Turgeon D, Carrier JS, Chouinard S, Belanger A. 2003. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos 31:670-676. (Pubitemid 36444177)
39. Wilson 3rd W, Pardo-Manuel de Villena F, Lyn-Cook BD, Chatterjee PK, Bell TA, Detwiler DA, Gilmore RC, Valladeras IC, Wright CC, Threadgill DWand others. 2004. Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707-714.
40. Xue Y, Sun D, Daly A, Yang F, Zhou X, Zhao M, Huang N, Zerjal T, Lee C, Carter NP and others. 2008. Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet 83:337-346.
41. Yang TL, Chen XD, Guo Y, Lei SF, Wang JT, Zhou Q, Pan F, Chen Y, Zhang ZX, Dong SS, Xu XH, Yan H, Liu X, Qiu C, Zhu XZ, Chen T, Li M, Zhang H, Zhang L, Drees BM, Hamilton JJ, Papasian CJ, Recker RR, Song XP, Cheng J, Deng HW. 2008. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet 83:663-674.